Press Releases
TriNetX Acquires Pharmacovigilance Leader Advera Health Analytics
The world’s largest real-world data network takes aim at improving drug safety Cambridge, MA, January 21, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the...
TriNetX Launches Machine Learning Capabilities on Global Real-World Data
Cambridge, MA, January 6, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of its Bring Your Own Model (BYOM) product, a major step forward for the...
TriNetX Launches Diversity Lens Analytic to Improve Access to Clinical Trials for Underrepresented Patient Populations
Cambridge, MA, December 9, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of Diversity Lens, an analytic feature on the TriNetX platform which helps...
TriNetX and Advarra Partner to Provide Enhanced Site Selection Services
Cambridge, MA, November 16, 2021 — TriNetX, the global health research network; and Advarra, the premier provider of independent review committees, quality and compliance consulting services, and research technology solutions; today announced a partnership that will...
TriNetX Announces the Appointment of Dr. Jeffrey Brown as Chief Scientific Officer
Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining the company as Chief Scientific Officer (CSO). Dr....
Colombia’s Clínica Imbanaco Joins the TriNetX Network to Increase International Research Collaboration
Clínica Imbanaco, a leading research organization in Colombia, has joined the TriNetX network to maximize its research capacity and to expand its collaboration with other research sites around the world. Headquartered in Cali, Colombia, Clínica Imbanaco’s Research Institute has participated in 143 industry-sponsored clinical trials since its founding in 2010.